Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Thrombotic“
Suchtreffer
Begriffe & Kennungen
Pemetrexed Accord · 4.5 · Interactions common to all cytotoxics: Due to the increased thrombotic risk in patients with cancer, the use o
Eintrag öffnenPemetrexed Fresenius Kabi · 4.5 · 46 Interactions common to all cytotoxics Due to the increased thrombotic risk in patients with cancer, the use
Eintrag öffnenPemetrexed Fresenius Kabi · 4.5 · Interactions common to all cytotoxics Due to the increased thrombotic risk in patients with cancer, the use of
Eintrag öffnenPemetrexed Fresenius Kabi · 4.5 · Interactions common to all cytotoxics Due to the increased thrombotic risk in patients with cancer, the use of
Eintrag öffnenPemetrexed Pfizer (previously Pemetrexed Hospira) · 4.5 · Due to the increased thrombotic risk in patients with cancer, the use of anticoagulation treatment is frequent
Eintrag öffnenPemetrexed Pfizer (previously Pemetrexed Hospira) · 4.5 · Due to the increased thrombotic risk in patients with cancer, the use of anticoagulation treatment is frequent
Eintrag öffnenPemetrexed medac · 4.5 · Due to the increased thrombotic risk in patients with cancer, the use of anticoagulation treatment is frequent
Eintrag öffnenPostthrombotisches Syndrom
Eintrag öffnenPrasugrel Viatris (previously Prasugrel Mylan) · 4.8 · System Organ Common Uncommon Rare Not known Class Thrombotic Blood and Lymphatic System Anaemia Thrombocytopae
Eintrag öffnenPurpura, thrombotisch-thrombozytopenische
Eintrag öffnenRetacrit · 4.3 · Surgery patients who for any reason cannot receive adequate antithrombotic prophylaxis.
Eintrag öffnenRetacrit · 4.8 · An increased incidence of thrombotic vascular events (TVEs) has been observed in patients receiving ESAs (see
Eintrag öffnenRevlimid · 4.8 · Concomitant administration of erythropoietic agents or previous history of DVT may also increase thrombotic ri
Eintrag öffnenRevolade · 4.8 · Thrombotic/thromboembolic events (TEEs)
Eintrag öffnenRevolade · 4.8 · Thrombotic/thromboembolic events (TEEs)
Eintrag öffnenRhapsido · 4.5 · Effect of remibrutinib on antithrombotic agents
Eintrag öffnenRivaroxaban Viatris (previously Rivaroxaban Mylan) · 4.8 · 10 Prevention of atherothrombotic 10,225 5 mg or 10 mg 31 months events in patients after an ACS respectively,
Eintrag öffnenRivaroxaban Viatris (previously Rivaroxaban Mylan) · 4.8 · Prevention of atherothrombotic 10,225 5 mg or 10 mg 31 months events in patients after an ACS respectively, co
Eintrag öffnenRivaroxaban Viatris (previously Rivaroxaban Mylan) · 4.8 · Prevention of atherothrombotic 10,225 5 mg or 10 mg 31 months events in patients after an acute respectively,
Eintrag öffnenRivaroxaban Viatris (previously Rivaroxaban Mylan) · 4.8 · Prevention of atherothrombotic 10,225 5 mg or 10 mg 31 months events in patients after an acute respectively,
Eintrag öffnen